Despite its growing popularity and use, bottom-up proteomics remains a complex analytical methodology. Its general workflow consists of three main steps: sample preparation, liquid chromatography coupled to tandem mass spectrometry (LC−MS/ MS), and computational data analysis. Quality assessment of the different steps and components of this workflow is instrumental to identify technical flaws and avoid loss of precious measurement time and sample material. However, assessment of the extent of sample losses along with the sample preparation protocol, in particular, after proteolytic digestion, is not yet routinely implemented because of the lack of an accurate and straightforward method to quantify peptides. Here, we report on the use of a microfluidic UV/ visible spectrophotometer to quantify MS-ready peptides directly in the MS-loading solvent, consuming only 2 μL of sample. We compared the performance of the microfluidic spectrophotometer with a standard device and determined the optimal sample amount for LC−MS/MS analysis on a Q Exactive HF mass spectrometer using a dilution series of a commercial K562 cell digest. A careful evaluation of selected LC and MS parameters allowed us to define 3 μg as an optimal peptide amount to be injected into this particular LC−MS/MS system. Finally, using tryptic digests from human HEK293T cells and showing that injecting equal peptide amounts, rather than approximate ones, result in less variable LC−MS/MS and protein quantification data. The obtained quality improvement together with easy implementation of the approach makes it possible to routinely quantify MS-ready peptides as a next step in daily proteomics quality control.
■ INTRODUCTION
Mass spectrometry (MS)-based proteomics is a key technology in modern life sciences, with a wide scope of applications for protein research. Due to technological advances in liquid chromatography (LC) and MS instrumentation, current LC− MS/MS systems perform at high sensitivity, resolution, and speed. 1−4 These improvements, coupled to robust bioinformatic pipelines, now allow routine in-depth proteome measurements at high confidence, explaining the success of the major proteomics applications today: quantitative measurements of proteomes by so-called shotgun proteomics, identification of protein interaction partners by affinity purification MS (AP-MS), and mapping of some of the most common post-translational modification (PTM) sites. LC−MS/MS systems are inherently prone to fluctuations in performance. Whether an ion source that gets transiently unstable in the course of an analytical run, a mass analyzer with a drift in accuracy, or a chromatographic column whose stationary phase progressively deteriorates, the different components of an LC−MS/MS system vary during the operation time. 5 Therefore, continuous monitoring is required to diagnose technical flaws and schedule maintenance interventions. For a very long time, however, guidelines and standardized methods to assess the quality of MS-based proteomics data were lacking. Over the last decade, great progress has been made in proteomics quality control. On the one hand, various reference sample formulations have been designed and are now commercialized as standards to carry out quality control (QC) analysis. 5, 6 On the other hand, a number of metrics to assess LC−MS/MS performance have been developed, 7, 8 in particular, for standard workflows of bottomup data-dependent analysis. Examples of QC metrics that inform about the liquid chromatography step are full-width at half-maximum (FWHM) of the eluting peptide peak and retention time drifts of eluting peptides, which monitor the integrity of the chromatographic column and the applied gradient. In turn, mass spectrometer QC can be done through examination of mass accuracy, dynamic range, and ion injection time. Importantly, various software tools for MSbased proteomics QC have been created, 9 which allow extraction and visualization of QC metrics from analytical runs performed on standard samples. One such example is a cloud-based quality control system QCloud that allows following instrument performance over time on a user-friendly web interface. 10 Of utmost importance for the success of a proteomic experiment is the QC assessment at the sample preparation level, where the major sources of variation arise from (1) artificial and thus unwanted in vitro protein/peptide modifications, (2) incomplete protein digestion, (3) protein contamination introduced by users or present in reagents, and (4) sample losses during sample transfer, enrichment steps, elution, and reconstitution. While the extent at which the first three types of variation compromise the quality of an analytical run can be quantified (provided that the correct identification search settings are used), no standardized QC procedures exist that account for analyte losses after proteolytic digestion. Indeed, while the extracted amount of protein material from cell or tissue samples is typically determined by standard assays immediately upon lysis and/or protein extraction, or prior to digestion ( Figure 1 ), no such established quantification procedures exist at the peptide level. An exception would be the bicinchoninic acid (BCA) method using a peptide digest sample standard, but its dependence on calibration and the consumption of large sample volumes make it lengthy and costly. Of particular note, even when additional modifications, enrichment steps, or cleaning procedures take place after digestion, which will inevitably introduce additional sample losses and variability, peptide quantification before the actual LC−MS/MS analysis is generally not performed.
LC−MS/MS runs carried out with insufficient amounts of peptides result in ion signals below the detection limit of the mass spectrometer, leading to low(er) numbers of peptide and protein identifications. In this respect, low signal-to-noise ratios of peptide signals also reduce the reliability of peptide quantification, as peak integration is more difficult for such low signals. Although analysis can be repeated by injecting more adequate sample amounts, this increases the overall analysis time and associated costs and is not always possible for lowquantity or low-volume samples. Equally troublesome is the injection of excessive amounts of peptide material, termed column overloading. Such column saturation leads to peak tailing and retention time shifts, 11−15 leading to poorer peptide separation and higher ionization competition, also reducing the number of identified and quantified peptides. 16 In some cases, this saturation can even lead to the obstruction of the column, which causes backpressure build-up, in turn increasing the variability between repeated analyses of similar samples.
Efforts to standardize procedures and minimize sample losses during sample preparation led to the development of simplified uniform protocols, including protocols in which all predigestion steps, such as lysis, protein reduction, and alkylation, are performed in a single volume. 17−19 Solid-phase extraction (SPE) to purify and concentrate peptides has also become a common practice at the end of the sample preparation protocol. Furthermore, automated sample preparation workflows 20, 21 or robotized systems start to become available, which allow accurate liquid handling, temperature control, and precise timing of processing steps. 22, 23 Some of these methods can be performed in miniaturized settings, which are advantageous when working with clinical or other low-abundance samples where analyte amounts are scarce. 22, 24 Even when optimized sample preparation protocols are in place, straightforward QC assessment at the peptide level would be highly desirable for monitoring sample losses, leading to injecting optimal peptide amounts for LC−MS/MS analysis. For such a procedure to be aligned with a miniaturized, highthroughput mass spectrometry workflow, it should allow (1) batchwise processing, (2) low sample consumption, and (3) execution just before LC−MS/MS analysis in the loading solvent used. Here, we present a procedure that complies with these requirements, based on peptide quantification directly in MS-loading buffer, in a microvolume, microfluidic, UV−visible spectrophotomer that can process several samples simultaneously. Using this procedure, we determined the optimal amount of peptides to be injected for shotgun measurements on our LC−MS/MS setup. Finally, we demonstrated that the application of this procedure for the control of sample loading improves LC−MS/MS and protein quantitation reproducibility. Peptide concentration is usually estimated based on protein quantification before proteolytic digestion (dark gray), but standard methods for performing this quantification at the peptide level, right before LC−MS/MS (red), would be highly desirable. Optional steps of the protocol are written in gray.
■ RESULTS AND DISCUSSION
The introduction of a peptide purification step prior to LC− MS/MS analysis 24 in routine in proteomics laboratories opened an opportunity to accurately determine peptide concentrations. Such a peptide purification step, typically based on solid-phase extraction (SPE), removes buffer components (like chaotropes, certain detergents, reducing/ alkylating reagents, and trypsin) that interfere with LC−MS/ MS analysis. As these components often absorb UV light, for a long time, they prevented routine, fast, and accurate peptide quantification, often leading to the analysis of suboptimal peptide amounts by LC−MS/MS. The high purity of peptides obtained after SPE led us to explore the possibility to quantify MS-ready peptide samples using a new-generation UV−visible spectrophotometer.
Simple Application for Accurate Quantification of MS-Ready Peptide Samples. The Lunatic instrument, from Unchained Labs, is a microfluidic spectrophotometer that performs DNA, RNA, protein, and peptide quantifications in batch, consuming only 2 μL of sample. Determination of peptide concentrations happens accurately by a proprietary software application that, from an acquired UV−visible absorbance spectrum, discriminates the signal coming from the UV-light-absorbing amino acids from those of usual contaminants (e.g., nucleic acids, cofactors). The "MS-peptide Quant" application quantifies peptides by taking into account the 280 nm molar extinction coefficient and the molecular weight of the average peptide species in a sample.
The ability to quantify complex peptide mixtures was verified using dilution series of commercial protein digests from yeast, ranging in concentration between 10 ng/μL and 1 μg/μL, based on the theoretical peptide quantity as reported by the vendor. Comparison between the theoretical concentration values and the measured ones in four independent replicate dilutions showed a high linear correlation (R 2 > 0.98) and a slope very close to 1 (t-test p-value = 0.19), demonstrating the instrument's high accuracy ( Figure 2 ). Meanwhile, it was noticed that peptide solutions with concentrations below 50 ng/μL gave absorbance measurements lower than 0.03, the lower absorbance limit at which the analyte concentration can be accurately assessed according to the instrument specifications. Therefore, it was concluded that solutions of peptides with concentrations between 50 ng/μL and 1 μg/μL are within the dynamic range of the instrument and can thus be accurately measured. This concentration range is well suited for MS-ready samples, for which LC−MS/MS experiments typically consume peptide quantities between 100 ng and 5 μg, contained in a volume of a few microliters.
We next compared peptide mixture quantification on our microfluidic device with quantification on a NanoDrop, a reference instrument among the class of microvolume spectrophotometers, which has also been used for measurements of MS-ready peptide samples. 25−27 In particular, we performed A280 measurements of five samples of HEK293 tryptic digests and compared across-instrument mean and coefficients of variation (CV) values. This analysis showed that quantification estimates differ slightly between instruments, with those from Lunatic always laying below those of NanoDrop (8−19% lower means across the five samples, Mann−Whitney U test p-value < 0.05) ( Figure S2 ). Furthermore, in terms of precision, this was visibly higher in Lunatic relative to NanoDrop (55−81% lower CV across the five samples).
In summary, together with its accuracy for the measurement of peptide solutions at commonly used concentration ranges, peptide quantitation with the Lunatic instrument presents a unique set of characteristics that make it particularly attractive over other quantification methods for MS-ready bottom-up proteomics samples (e.g., Bradford, Lowry, BCA, Pierce 660 nm, tryptophan fluorescence, 28 and other A280 methods). It is a quick and easy method that can be performed in batch. It only implies a very low, 2 μL, sample consumption. It is based on UV light absorbance at 280 nm, an intrinsic property of aromatic amino acids, thus requiring no calibration curve, unlike colorimetric reaction-based assays like Bradford or BCA. Finally, with this instrument, it is possible to reach a higher level of precision than with other reference spectrophotometers also performing A280-based peptide quantification.
Determination of an Optimal Peptide Amount for LC−MS/MS Analysis. The ideal peptide amount to use for LC−MS/MS to have a maximum throughput and identification rate, while keeping a good analyte separation, will largely depend on the characteristics of the LC−MS/MS system, namely, on its chromatographic column loading capacity. If the exact sample concentration would be known, it would be possible to always work with optimal sample amounts and thus consistently get high-quality LC−MS/MS runs.
Therefore, taking advantage of peptide quantification by the microfluidic spectrophotometer, we set out to determine the most suitable sample loading for an LC−MS/MS setup routinely used in our laboratory: a 40 cm LC column packed in the needle with 1.9 μm C18 beads coupled to a Q Exactive HF mass spectrometer.
Starting from a commercial tryptic digest of a K562 cell lysate, we prepared 10 different samples, from which 5 μL, containing peptide amounts ranging from 0.06 to 12 μg, was injected for LC−MS/MS analysis using a 2.5 h gradient. The experiment was repeated to generate data for two independent series of replicates analyzed on two different LC columns (Figures 3 and S3 ).
All peptide concentration measurements were lower than predicted ( Figure 3a ). Likely, these deviations arose mostly from peptide losses during peptide resuspension of the K562 digest, as additional losses during the preparation of serially diluted samples were minor (R 2 > 0.99 for the comparison of theoretical vs measured sample concentrations). We also noticed that peptide quantification of #Dilution 1 and 2, having theoretical concentrations of 0.013 and 0.025 μg/μL, respectively, returned negative values. These clearly inaccurate Based on numbers of identified and quantified proteins a rather broad window ranging from 1.49 to 5.20 μg of peptides was found as an optimal injection amount. (d) Scatter plots of average MS2 ion injection time, median peak area, and median signal-to-noise ratio (S/N) of identified peptides in each analytical run. (e) Scatter plots of the median peak area of hydrophilic, intermediate hydrophobic, and hydrophobic identified peptides. For both replicate series, from around 2−3 μg, peak areas decline steeply for hydrophilic peptides, while they go up progressively for hydrophobic peptides, two types of peptide classes having a lower and higher affinity for the used precolumn, respectively. Colors represent the results of two replicate series analyzed on two different LC columns. Loss curve fitting was used to generate the connecting lines. Based on the loss of hydrophilic peptides, 3 μg was defined as an optimal peptide injection amount for this particular LC−MS/MS setup (dashed lines). measurements were performed below the limit of detection of the spectrophotometer.
To find an optimal peptide amount to inject into our LC− MS/MS setup, we evaluated the rates of identified and quantified proteins. To this end, the LC−MS/MS data were searched with MaxQuant 29 and identified proteins were quantified by the MaxLFQ algorithm 30 (Figures 3b,c and S3 and Table S1 ). The number of identified peptides reached a maximum between 1.49 and 3.28 μg and showed a marked decrease for higher peptide amounts (18−20% reduction in the number of identified peptides for the 10.99 μg samples), likely due to column overloading. In turn, identified and quantified protein numbers increased with the injected peptide amount until 3.28−5.20 μg, above which they started to level off and the same trend was seen for individual proteins ( Figure  S3 ). Based on these numbers, a rather broad window ranging from approximately 1.49−5.20 μg of peptides was found as an optimal peptide injection amount for our LC−MS/MS setup.
In an attempt to further narrow down this window, we evaluated selected LC and MS parameters. The efficient time consumption of a mass spectrometer is, among other things, reflected by the ion injection time. The closer to ideal the amount of material presented to the mass spectrometer is, the lower the injection time will be. Figure 3d (left panel) shows that MS2 ion injection time reached an optimal minimum around an average amount of 3.28 μg of injected peptides. We also assessed the two LC parameters signal-to-noise (S/N) ratio of chromatographic peaks and peak areas. Figure 3d (right panel) shows that the average S/N ratio increased with increasing peptide amounts and again leveled off at an average sample amount of about 3.28 μg. Analysis of the median peak area of all identified peptides showed a maximum between 5.20 and 7.08 μg for the two replicate experiments (Figure 3d , middle). When overloading a reversed-phase C18 column, one expects peak tailing, with a concomitant increase of the average peak area due to repulsion effects of same-charge ions. 13−15 The observed leveling off and even decrease in the peak area at higher loads though contradicted this expectation. To explore this further, we split peptides according to their retention time interval in three parts: early eluting peptides (hydrophilic, n = 126), late eluting peptides (hydrophobic, n = 178), and the ones eluting in between (mid eluting/intermediate hydrophobic peptides, n = 2304) ( Figure S1 ). Such partitioning procedure revealed that the registered decrease in peak areas was due to a steep decline of hydrophilic peptides peak areas (Figure 3e ) starting from 2−3 μg of sample due to the use of a trapping column in our LC−MS/MS setup, whose capacity did not allow retention of the most hydrophilic peptides for higher sample amounts, leading to this trend for hydrophilic peptides loss.
The disadvantage of losing hydrophilic peptides does not overrule the advantages of using a trapping column though if void volumes are avoided. 31 Therefore, based on the loss of hydrophilic peptides for amounts above 2.86 and 2.63 μg for replicate series 1 and 2, respectively (peptide amounts that correspond to the peak maxima in the hydrophilic peptides peak area plot), together with the stabilization of the other parameters also around these sample amounts, we now routinely use 3 μg of peptides as an optimal injection amount on this particular LC−MS/MS setup.
By running a series of LC−MS/MS analysis, covering a range of known peptide sample amounts, and performing a follow-up evaluation of the numbers of identified and quantified features, as well as of a few LC and MS parameters, we were able to identify 3 μg as an optimal amount of injected peptides for our LC−MS/MS setup. This procedure could be applied to any other system and as such be of great use in proteomics laboratories. Indeed, knowledge about the most adequate sample amounts to use is currently not known for most systems. As a workaround to deal with this lack of information, it is common to either inject different concentrations of the same sample or else to perform short off-line analytical runs to fine-tune sample loading for a given sample. 32 However, these strategies are time-and cost- ineffective and often consume higher amounts of precious sample material than the simple UV-based procedure described here.
Control over Peptide Amount Injections Effectively Stabilizes LC−MS/MS and Protein Quantitation Reproducibility. During sample preparation, it is common to make the protein amounts for all samples of a batch even before proceeding to the digestion step. This will generate very equivalent MS samples that can then be injected for LC−MS/ MS using equal volumes. We decided to evaluate whether, in comparison to that approach, performing peptide quantification prior to MS and concomitantly adjusting injection volumes to account for small differences in samples concentrations would have an impact on the reproducibility of LC−MS/MS and, in particular, of quantitation data.
To this end, we analyzed five tryptic digests of HEK293 cells, prepared in parallel starting from five different cell pellets. On the first set of analytical runs, we corrected for the peptide amounts loaded based on measured sample concentration, having injected exactly 3.0 μg of peptide mixture for all five replicates. In contrast, on the second set of runs of the same samples, we injected a fixed volume, corresponding to the average used for the first experiment. After calculating the peptide loadings for this second experiment, we realized there was a difference of 1 μg between the lowest and highest concentrations of the sample (2.5 and 3.55 μg, respectively). These differences are quite substantial and show the importance of accurate peptide quantitation of MS-ready samples. Even with the automation of sample preparation, which should alleviate heterogeneity between samples, peptide quantitation could always be kept as a quality check step.
For both sets, the previously used MS and LC parameters were examined (Figure 4a ). Strikingly, while all MS injection time, peak area, and S/N noise ratio values were close to each other in the experiment with the "corrected" sample amounts, these showed a much higher spread in the second experiment where each analytical run had a different sample amount. Indeed, the standard deviation for the MS2 injection time, peak area, and S/N ratio had a tenfold, threefold, and twofold increase, respectively, for the "noncorrected" experiment relative to the corrected experiment ( Figure 4a ).
Finally, we checked whether this higher analytical reproducibility also resulted in a more precise protein quantification. To this end, we looked at the distribution of the coefficients of variation (CV) of raw protein intensity values from corrected replicates versus those from noncorrected replicates. In addition, we compared the CV distributions for label-free quantitation (LFQ) protein intensity values obtained after normalization by the MaxLFQ algorithm. As expected, CV values for the non-normalized intensities were significantly lower for the corrected experiment (Figure 4b , Mann− Whitney U test p-value < 2.2 × 10 −16 ). However, a shift toward lower CV values was also observed for the normalized LFQ intensities of the corrected experiment (Mann−Whitney U test p-value < 2.2 × 10 −16 ), indicating that computational normalization cannot fully compensate for differences in injection amounts. Such a reduction in the dispersion of protein quantification estimates can potentially improve the sensitivity for detecting peptide and protein regulation. Together, these data show that working consistently with equal peptide amounts results in increased reproducibility LC−MS/MS and protein quantification data, even in combination with the normalization of protein intensities during data analysis.
■ CONCLUSIONS
In the present work, we describe a simple procedure to quantify MS-ready peptides using a microfluidic UV−visible spectrophotometer. This instrument, with its integrated peptide quantification software application, constitutes an accurate and easy-to-use device for the implementation of peptide quantification in proteomics laboratories and facilities. Through careful control of the injected peptide amount on a commonly used LC−MS/MS setup, we show how this procedure can provide a constant quality boost to MS-based proteome analyses. The application of this methodology on a routine basis can drastically reduce time and sample losses by avoiding reruns after the injection of suboptimal peptide amounts.
■ METHODS Sample Preparation. HEK293 cells (5 × 5 × 10 6 ) were harvested, washed 3 times in phosphate-buffered saline (PBS), and resuspended in lysis buffer (8 M urea; 20 mM HEPES, pH 8.0). Samples were sonicated by three pulses of 15 s, interspaced by 1 min pauses on ice, at an intensity output of 15 W, and centrifuged for 15 min at 20 000g at room temperature to remove insoluble components. The protein concentration in the supernatants of each sample was measured using a Bradford assay (Bio-Rad), and equal protein amounts (500 μg each) were used for further analysis. Proteins were reduced with 5 mM dithiothreitol (DTT) (Sigma-Aldrich) for 30 min at 55°C. Alkylation was performed by the addition of 10 mM iodoacetamide (Sigma-Aldrich) for 15 min at room temperature in the dark. The samples were diluted with 20 mM N-(2-hydroxyethyl)piperazine-N′-ethanesulfonic acid (HEPES), pH 8.0, to a urea concentration of 4 M, and proteins were pre-digested with 5 μg of endoLysC (Wako, 129−02541) (1/100, w/w) for 4 h at 37°C. All samples were further diluted with 20 mM HEPES, pH 8.0, to a final urea concentration of 2 M, and proteins were digested with 5 μg of trypsin (V5111, Promega) (1/100, w/w) overnight at 37°C. Peptides were then purified on a SampliQ SPE C18 cartridge (Agilent), vacuum-dried, and kept at −20°C until further use.
Peptide Concentration Measurements. Quantification of peptide mixtures was based on the UV absorbance of aromatic amino acids at 280 nm (A280), on the following spectrophotometer models: a Lunatic microfluidic device (Unchained Labs) and NanoDrop ND-1000 (Thermo Fisher Scientific). In the case of Lunatic, peptide concentrations were determined by the instrument's MS-peptide Quant tool, while the "A280" application was used with NanoDrop, with the sample type option set to "1 Abs = 1 mg/mL".
Linear Dynamic Range Determination. The linear dynamic range for measurement of complex peptide mixtures on the microfluidic spectrophotometer was determined on a group of eight solutions prepared from a 1.0 μg/μL stock of a commercial yeast protein digest (Promega, V7461), dissolved in loading solvent (0.1% trifluoroacetyl (TFA) in acetonitrile/ water, 2:98 (v/v)). Measurements of solutions in the 1.0 μg/ μL to 10 ng/μL concentration range (used concentrations were 0.010, 0.025, 0.050, 0.100, 0.250, 0.500, 0.750, and 1.000 μg/μL) were done in quadruplicate, from four yeast protein digest vials, and at least two readouts per solution were taken.
Comparison of Peptide Quantification in Distinct
Microvolume Spectrophotometers. Quantification of peptide mixtures in the two microvolume spectrophotometers was carried out on five samples of HEK293 tryptic digest (n = 10 repeated measurements each sample). Sample means and coefficients of variation (CV) were compared.
Assessment of Optimal Loading Amount. A commercially available K562 cell digest (Promega, V6951) was used to create a twofold dilution series ranging from 0.013 to 2.4 μg/ μL. Peptide amounts ranging from 0.06 μg up to 12 μg were loaded on an LC−MS/MS system. In parallel, the actual sample concentration values were assessed with the MSpeptide Quant method (see Figure 3a ). The same experiment was repeated using a new K562 cell vial to prepare the dilution series and a different analytical column.
Assessment of LC−MS/MS Analysis Quality under Controlled Sample Loading Conditions. Five HEK293 protein digest samples were resuspended in 30 μL of MSloading solvent (0.1% TFA in acetonitrile/water, 2:98 (v/v)) and measured with MS-peptide Quant. Two sets of LC−MS/ MS analytical runs followed. In the first one, 3.0 μg of peptide mixture from each sample was loaded onto the LC−MS/MS system, while in the second one, the same sample volume was used for all five injections, resulting in peptide amounts ranging from 2.50 to 3.55 μg (detailed in the Results section).
LC−MS/MS Analysis. From each sample, 5 μL was introduced into an LC−MS/MS system through an Ultimate 3000 RSLC nano LC (Thermo Fisher Scientific, Bremen, Germany) in-line connected to a Q Exactive HF mass spectrometer (Thermo Fisher Scientific). The sample mixture was first loaded on a trapping column (made in-house, 100 μm internal diameter (I.D.) × 20 mm, 5 μm beads C18 Reprosil-HD, Dr. Maisch, Ammerbuch-Entringen, Germany). After flushing from the trapping column, the sample was loaded on an analytical column (made in-house, 75 μm I.D. × 400 mm, 1.9 μm beads C18 Reprosil-HD, Dr. Maisch) packed in the needle (pulled in-house). Peptides were loaded with the loading solvent (0.1% TFA in acetonitrile/water, 2:98 (v/v)) and eluted with a nonlinear 150 min gradient of 2−56% solvent B (0.1% formic acid in water/acetonitrile, 20:80 (v/v)) at a flow rate of 250 nL/min. This was followed by a 15 min wash reaching 99% solvent B and re-equilibration with solvent A (0.1% formic acid). The column temperature was kept constant at 50°C (CoControl 3.3.05, Sonation).
The mass spectrometer was operated in data-dependent, positive ionization mode, automatically switching between MS and MS/MS acquisition for the 16 most abundant peaks in a given MS spectrum. The source voltage was set to 3.0 kV, and the capillary temperature was 250°C. Full-scan MS spectra (375−1500 m/z, AGC target 3 × 10 6 ions, maximum ion injection time of 45 ms) were acquired at a resolution of 60 000 (at 200 m/z) in the orbitrap analyzer, followed by up to 16 tandem MS scans (resolution 15 000 at 200 m/z) of the most intense ions fulfilling predefined selection criteria (AGC target, 1 ×10 5 ions; maximum ion injection time, 60 ms; isolation window, 1.5 m/z; fixed first mass, 145 m/z; spectrum data type, centroid; underfill ratio, 2%; intensity threshold, 1.3 × 10 4 ; exclusion of unassigned, singly, and >7 charged precursors; peptide match preferred; exclude isotopes on; and dynamic exclusion time, 12 s). The higher collisional dissociation (HCD) collision energy was set to 28% of the normalized collision energy and the polydimethylcyclosiloxane background ion at 445.12002 Da was used for internal calibration (lock mass).
Data Analysis. Data analysis was performed with MaxQuant software (version 1.6.1.0). 29 The Andromeda search engine was used with default settings, including PSM, peptide, and protein false discovery rate set at 1% and match between runs disabled. Spectra were searched against the U n i P r o t r e f e r e n c e p r o t e o m e r e l e a s e 2 0 1 8 _ 0 1 (UP000005640_9606, containing 21007 human protein entries) with a mass tolerance for precursor and fragment ions of 4.5 and 20 ppm, respectively. The oxidation of methionine residues and acetylation of protein N-termini were defined as variable modifications, while carbamidomethylation of cysteine residues was set as a fixed modification. Proteins with at least one unique or razor peptide were retained and then quantified by the MaxLFQ algorithm integrated into the MaxQuant software. 30 A minimum ratio count of two unique or razor peptides was required for quantification. Further data analysis was performed with the Perseus software (version 1.6.1.3) after loading the protein groups file from MaxQuant. The number of protein identifications was given by the number of protein groups obtained after filtering out protein groups only identified by site, reverse database hits, and potential contaminants. The number of peptide identifications was obtained after the exclusion of reverse database hits and potential contaminants. Quantified proteins were the subset of identified proteins with positive LFQ intensities. Heat maps were prepared from matrices of log 2-transformed LFQ protein expression values, after filtering for at least three valid values over all samples. Proteins were displayed according to the order of groups defined by hierarchical clustering using Euclidean distances and average linkage settings.
The chromatographic parameters signal-to-noise (S/N) ratio and peak area were obtained using the moFF algorithm, 33 executed on each analytical run. Peak areas were approximated by the area of a triangle of base equal to the peak width (in minutes) and height given by the peak's apex intensity. The MS2 injection time was retrieved from MaxQuant's MS/MS scans table. This analysis was done on peptide-to-spectrum matches from features detected in every analytical run from each experiment. Peptides were partitioned according to hydrophobicity by the following way: hydrophilic peptides were those eluting until 50 min of the LC gradient (1.6−12.3% acetonitrile), intermediate hydrophobic peptides were eluted between 50 and 110 min (12.3−26.6% acetonitrile), and hydrophobic peptides were eluted after 110 min (26.6−79.2% acetonitrile) ( Figure S1 ).
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http:// proteomecentral.proteomexchange.org) via the PRIDE partner repository with the identifier 10.6019/PD014524.
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